Professional Experience
Professor Albiges currently holds a leading role at Gustave Roussy, one of the largest cancer centers in Europe. She combines clinical practice, leadership, and academic contributions in her work.
- Head of Genitourinary Oncology Department, Gustave Roussy, Villejuif, France
- Extensive experience in managing advanced and rare genitourinary cancers
- Clinical trial leader bringing new therapies into practice for patients worldwide
- Mentor and supervisor for junior doctors, residents, and research fellows
Academic Contributions
Professor Albiges is active in teaching, mentorship, and international conferences. Her academic contributions enhance cancer care worldwide.
- Lecturer at national and international oncology conferences
- Instructor for advanced oncology courses for medical students and residents
- Mentorship of PhD students and clinical fellows in oncology research
- Frequent invited speaker at European and global cancer research meetings
Areas of Expertise
Her clinical and research expertise spans a wide range of cancers affecting the urinary and reproductive systems. She focuses on providing advanced and personalized treatment strategies.
- Kidney cancer – advanced and metastatic treatment strategies
- Prostate cancer – innovative therapies including immunotherapy and precision medicine
- Bladder cancer – combined treatment protocols involving surgery, chemotherapy, and immunotherapy
- Clinical trials – early access to new cancer treatments
Publications and Research
Professor Albiges is a widely published researcher with numerous contributions to peer-reviewed journals. Her work focuses on improving survival and quality of life for patients with genitourinary cancers.
Some notable publications include:
- Research on novel immunotherapy combinations for renal cell carcinoma
- Studies on predictive biomarkers for response to targeted therapies
- Clinical trials evaluating new drugs in prostate and bladder cancer
Her research is frequently cited in PubMed-indexed journals and contributes to international oncology guidelines.
Patient Care Philosophy
Professor Albiges is committed to patient-centered oncology care, emphasizing empathy, clear communication, and individualized treatment plans. She believes in combining evidence-based medicine with compassionate support for patients and their families.
- Focus on transparent communication to help patients make informed decisions
- Commitment to improving patient quality of life alongside clinical outcomes
- Experience in supporting international patients seeking treatment in France
- Belief in multidisciplinary care involving oncologists, surgeons, radiologists, and supportive specialists
Professional Affiliations
Professor Albiges is a recognized member of leading oncology organizations, contributing to international cancer research and policy development.
- Member of the European Society for Medical Oncology (ESMO)
- Contributor to American Society of Clinical Oncology (ASCO) initiatives
- Active role in French national oncology research groups
- Editorial board member and peer reviewer for top oncology journals
FAQs
- Is Laurence Albiges board-certified?
- Yes, Professor Albiges is board-certified in oncology and has extensive training in cancer treatment and research.
- What types of cancers does she treat?
- She specializes in kidney, prostate, and bladder cancers, with expertise in advanced and complex cases.
- Does she treat international patients?
- Yes, Professor Albiges regularly sees patients from abroad as part of Gustave Roussy’s international patient program.
- How long is the typical hospital stay for oncology treatment?
- The length of stay depends on the type of cancer and treatment plan. Some therapies are outpatient, while others may require several weeks of hospitalization.
- What languages does she speak?
- Professor Albiges speaks French and English, allowing her to communicate effectively with international patients.
- Is she involved in cancer research?
- Yes, she is an active researcher and clinical trial leader with numerous publications in peer-reviewed journals.
